TCL Archive Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities April 28, 1995
TCL Archive Senate Gives NIH Director Authority To Permit Research By Unconventional MDs September 25, 1992
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013